GGrantIndex
← Leaderboards

Timothy J Ley

Washington University

$36,060,228
Attributed
$36,060,228
Total exposure
24
Grants
22
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.5M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$94,869,617 · 25

By mechanism

P01$65,785,631 · 8
R01$11,261,853 · 3
R35$10,052,833 · 1
P50$3,624,842 · 3
R37$2,419,128 · 1
P30$1,579,888 · 4

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Mutation

Research focus

MutationGenomicsGenesSamplingCellsGenomePathogenesisBaseGenome SequencingMolecularMutantAcute Myelocytic LeukemiaEventMouse ModelResistanceTumorRelapseMemberLeukemia, Myelocytic, AcutePathway InteractionsWhole GenomeTranscriptome SequencingProgramsPattern

Grant awards (142)

Molecular Pathogenesis of Acute Myeloid Leukemia$932,549
R35 · FY2025 · CA · contact PI
Career Enhancement Program$129,987
P50 · FY2025 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$885,386
R35 · FY2024 · CA · contact PI
Career Enhancement Program$124,787
P50 · FY2024 · CA · contact PI
Genomics Of Acute Myeloid Leukemia.$3,144,604
P01 · FY2023 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$914,339
R35 · FY2023 · CA · contact PI
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.$431,397
P01 · FY2023 · CA · contact PI
Core D: Administration Core.$108,891
P01 · FY2023 · CA · contact PI
Genomics Of Acute Myeloid Leukemia.$3,081,712
P01 · FY2022 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$944,000
R35 · FY2022 · CA · contact PI
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.$433,281
P01 · FY2022 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$329,194
P50 · FY2022 · CA · contact PI
Core D: Administration Core.$42,792
P01 · FY2022 · CA · contact PI
Genomics Of Acute Myeloid Leukemia.$3,144,604
P01 · FY2021 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2021 · CA · contact PI
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.$437,796
P01 · FY2021 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$276,134
P50 · FY2021 · CA · contact PI
Core D: Administration Core.$78,212
P01 · FY2021 · CA · contact PI
Genomics Of Acute Myeloid Leukemia.$3,142,107
P01 · FY2020 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2020 · CA · contact PI
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.$442,752
P01 · FY2020 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$346,707
P50 · FY2020 · CA · contact PI
Core D: Administration Core.$45,095
P01 · FY2020 · CA · contact PI
Genomics Of Acute Myeloid Leukemia.$2,084,756
P01 · FY2019 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$886,559
R35 · FY2019 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$317,882
P50 · FY2019 · CA · contact PI
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.$238,506
P01 · FY2019 · CA · contact PI
Core D: Administration Core.$42,833
P01 · FY2019 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$1,458,713
P01 · FY2018 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2018 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$342,783
P50 · FY2018 · CA · contact PI
Genomics of AML Clonality$178,241
P01 · FY2018 · CA · contact PI
Administration$32,820
P01 · FY2018 · CA · contact PI
Project 1 - Molecular Determinants of Decitabine Responses.$6,632
P50 · FY2018 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,917,422
P01 · FY2017 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2017 · CA · contact PI
Molecular Determinants of Decitabine Response$391,498
P50 · FY2017 · CA · contact PI
Genomics of AML Clonality$328,402
P01 · FY2017 · CA · contact PI
Administration$127,287
P01 · FY2017 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,888,289
P01 · FY2016 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2016 · CA · contact PI
Molecular Determinants of Decitabine Response$368,008
P50 · FY2016 · CA · contact PI
Genomics of AML Clonality$331,298
P01 · FY2016 · CA · contact PI
Administration$150,298
P01 · FY2016 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,861,276
P01 · FY2015 · CA · contact PI
Molecular Pathogenesis of Acute Myeloid Leukemia$915,000
R35 · FY2015 · CA · contact PI
Molecular Determinants of Decitabine Response$335,554
P50 · FY2015 · CA · contact PI
Genomics of AML Clonality$330,644
P01 · FY2015 · CA · contact PI
Administration$149,644
P01 · FY2015 · CA · contact PI
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA$72,577
R01 · FY2015 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,749,891
P01 · FY2014 · CA · contact PI
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA$423,527
R01 · FY2014 · CA · contact PI
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL$376,310
R01 · FY2014 · CA · contact PI
Molecular Determinants of Decitabine Response$325,157
P50 · FY2014 · CA · contact PI
Genomics of AML Clonality$320,105
P01 · FY2014 · CA · contact PI
Administration$144,533
P01 · FY2014 · CA · contact PI
Embryonic Stem Cell Core$139,838
P30 · FY2014 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,809,295
P01 · FY2013 · CA · contact PI
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA$411,538
R01 · FY2013 · CA · contact PI
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL$366,284
R01 · FY2013 · CA · contact PI
Molecular Determinants of Decitabine Response$330,519
P50 · FY2013 · CA · contact PI
Genomics of AML Clonality$329,378
P01 · FY2013 · CA · contact PI
Administration$148,380
P01 · FY2013 · CA · contact PI
Embryonic Stem Cell Core$137,891
P30 · FY2013 · CA · contact PI
Embryonic Stem Cell Core$75,000
P30 · FY2013 · CA · contact PI
Embryonic Stem Cell Core$41,666
P30 · FY2013 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$3,185,249
P01 · FY2012 · CA · contact PI
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA$439,014
R01 · FY2012 · CA · contact PI
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL$391,427
R01 · FY2012 · CA · contact PI
Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences$278,939
P01 · FY2012 · CA · contact PI
Embryonic Stem Cell Core$143,764
P30 · FY2012 · CA · contact PI
Administration$42,808
P01 · FY2012 · CA · contact PI
Embryonic Stem Cell Core$2,777
P30 · FY2012 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,733,974
P01 · FY2011 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,329,096
P01 · FY2011 · CA · contact PI
Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences$449,473
P01 · FY2011 · CA · contact PI
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA$408,804
R01 · FY2011 · CA · contact PI
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL$393,245
R01 · FY2011 · CA · contact PI
Embryonic Stem Cell Core$90,577
P30 · FY2011 · CA · contact PI
Administration$87,052
P01 · FY2011 · CA · contact PI
DMNT3A MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA$14,160
P41 · FY2011 · RR · contact PI
Genomics of Acute Myelogenous Leukemia$2,824,905
P01 · FY2010 · CA · contact PI
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL$407,339
R01 · FY2010 · CA · contact PI
Genomics of Acute Myelogenous Leukemia (2PO1CA101937-06)$313,242
P01 · FY2010 · CA · contact PI
Genomics of AML: Whole Genome Resequencing$313,242
P01 · FY2010 · CA · contact PI
Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences$251,610
P01 · FY2010 · CA · contact PI
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PRODUCTION$99,999
R56 · FY2010 · DK · contact PI
Embryonic Stem Cell Core$95,517
P30 · FY2010 · CA · contact PI
Administration$48,462
P01 · FY2010 · CA · contact PI
ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$9,710
P41 · FY2010 · RR · contact PI
Genomics of Acute Myelogenous Leukemia$2,775,922
P01 · FY2009 · CA · contact PI
The Biology of Promyelocytic Leukemia in a Mouse Model$414,160
R01 · FY2009 · CA · contact PI
Role of Granzymes in Cytotoxic Lymphocyte Functions$334,102
R01 · FY2009 · DK · contact PI
Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences$248,087
P01 · FY2009 · CA · contact PI
Administration$47,495
P01 · FY2009 · CA · contact PI
ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$8,730
P41 · FY2009 · RR · contact PI
Genomics of Acute Myelogenous Leukemia$2,759,945
P01 · FY2008 · CA · contact PI
The Biology of Promyelocytic Leukemia in a Mouse Model$403,533
R01 · FY2008 · CA · contact PI
Role of Granzymes in Cytotoxic Lymphocyte Functions$334,102
R01 · FY2008 · DK · contact PI
Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences$290,087
P01 · FY2008 · CA · contact PI
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PROD$282,121
R37 · FY2008 · DK · contact PI
Core--Embryonic Stem Cell Facility$261,525
P30 · FY2008 · CA · contact PI
Administration$46,402
P01 · FY2008 · CA · contact PI
ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$12,843
P41 · FY2008 · RR · contact PI
Genomics of Acute Myelogenous Leukemia$424,680
P01 · FY2007 · CA · contact PI
The Biology of Promyelocytic Leukemia in a Mouse Model$401,004
R01 · FY2007 · CA · contact PI
Role of Granzymes in Cytotoxic Lymphocyte Functions$340,919
R01 · FY2007 · DK · contact PI
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PROD$279,491
R37 · FY2007 · DK · contact PI
Core--Embryonic Stem Cell Facility$274,043
P30 · FY2007 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,875,937
P01 · FY2006 · CA · contact PI
The Biology of Promyelocytic Leukemia in a Mouse Model$402,462
R01 · FY2006 · CA · contact PI
Role of Granzymes in Cytotoxic Lymphocyte Functions$351,101
R01 · FY2006 · DK · contact PI
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PROD$279,460
R37 · FY2006 · DK · contact PI
Core--Embryonic Stem Cell Facility$105,457
P30 · FY2006 · CA · contact PI
Genomics of Acute Myelogenous Leukemia$2,880,629
P01 · FY2005 · CA
The Biology of Promyelocytic Leukemia in a Mouse Model$401,685
R01 · FY2005 · CA
Role of Granzymes in Cytotoxic Lymphocyte Functions$359,550
R01 · FY2005 · DK
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PROD$277,848
R37 · FY2005 · DK
Core--Embryonic Stem Cell Facility$102,385
P30 · FY2005 · CA
Genomics of Acute Myelogenous Leukemia$2,804,775
P01 · FY2004 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.$433,099
R01 · FY2004 · CA
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$352,182
R01 · FY2004 · DK
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PROD$269,756
R37 · FY2004 · DK
Core--Embryonic Stem Cell Facility$99,403
P30 · FY2004 · CA
Hematopoietic Development and Malignancy Program$10,045
P30 · FY2004 · CA
Genomics of Acute Myelogenous Leukemia$2,618,366
P01 · FY2003 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.$422,692
R01 · FY2003 · CA
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$352,182
R01 · FY2003 · DK
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PRODUCTI$266,966
R37 · FY2003 · DK
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.$412,588
R01 · FY2002 · CA
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$352,182
R01 · FY2002 · DK
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PRODUCTI$261,169
R37 · FY2002 · DK
CORE--EMBRYONIC STEM CELL$0
P30 · FY2002 · CA
STEM CELL BIOLOGY$0
P30 · FY2002 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.$403,433
R01 · FY2001 · CA
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$352,182
R01 · FY2001 · DK
REGULATION OF FETAL AND ADULT HUMAN HEMOGLOBIN PRODUCTI$254,871
R37 · FY2001 · DK
CORE--EMBRYONIC STEM CELL$0
P30 · FY2001 · CA
STEM CELL BIOLOGY$0
P30 · FY2001 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.$396,448
R01 · FY2000 · CA
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONS$352,182
R01 · FY2000 · DK
FETAL AND ADULT HUMAN HEMOGLOBIN PRODUCTION$247,446
R37 · FY2000 · DK